DRUG DEVELOPMENT, EVOLVED

DRUG DEVELOPMENT, EVOLVED

AxoSim empowers advancements in human neuroscience and accelerates the drug development process through our drug discovery platforms, NerveSim® and BrainSim®

Learn More

Sign up here for our Webinar: Scaling Peripheral Nerves: A Case Study on CIPN

ACCURACY Icon

ACCURACY

Our technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.

EFFICIENCY Icon

EFFICIENCY

Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.

CLINICAL SUCCESS Icon

CLINICAL SUCCESS

Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.

NerveSim®

How it Works

AxoSim's NerveSim® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.

BrainSim®

How it Works

BrainSim® is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.

News & Publications

Our Partners & Funders